Joó I, Csizér Z
Bull World Health Organ. 1978;56(4):615-8.
a plain vaccine and an aluminium hydroxide-adsorbed vaccine, by using the Inaba NIH 35A3 and Ogawa NIH 41 serotypes of Vibrio cholerae. For cultivation, a solid medium was used and the cultures were inactivated with 0.02% thiomersal and by heating for 1 hour at 56 degrees C. The final vibrio concentration of the vaccines was adjusted to 16 x 10(9) vibrios/ml (equal proportions of the two serotypes). The antigenicity of the vaccines was assessed by the active mouse protection test and by the antibody production test, i.e. by determinating the vibriocidal antibodies in the sera of immunized mice. The results of the active mouse protection test showed that the antigenicity of the Inaba and Ogawa components of both vaccines met the WHO Requirements. The antigenicity of the Inaba component of both vaccines was about the same. The antigenicity of the Ogawa component of the plain vaccine appeared to be somewhat higher than that of the adsorbed vaccine. In the antibody production test, the adsorbed vaccine elicited a higher and longer-lasting immune response than the plain vaccine.
一种是普通疫苗,另一种是氢氧化铝吸附疫苗,使用的是霍乱弧菌稻叶型NIH 35A3和小川型NIH 41血清型。培养时使用固体培养基,培养物用0.02%硫柳汞并在56℃加热1小时进行灭活。疫苗的最终弧菌浓度调整为16×10⁹弧菌/毫升(两种血清型比例相等)。通过活性小鼠保护试验和抗体产生试验评估疫苗的抗原性,即通过测定免疫小鼠血清中的杀弧菌抗体。活性小鼠保护试验结果表明,两种疫苗的稻叶型和小川型成分的抗原性均符合世界卫生组织的要求。两种疫苗的稻叶型成分的抗原性大致相同。普通疫苗的小川型成分的抗原性似乎略高于吸附疫苗。在抗体产生试验中,吸附疫苗比普通疫苗引发更高且更持久的免疫反应。